Skip to content

Clinical trials

Phase 2/3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2/3 Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20041
20051
20061
20071
20083
20093
20101
20111
20131
20151
20164
20171
20181
20192
20201
20212
20221
20231
20241
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status11
Recruiting8
Terminated4
Active, not recruiting3
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University4
Federal Research Institute of Pediatric Hematology, Oncology and Immunology3
Institute of Hematology & Blood Diseases Hospital, China3
Assistance Publique - Hôpitaux de Paris2
Tehran University of Medical Sciences2
Acacia Pharma Ltd1
Ann & Robert H Lurie Children's Hospital of Chicago1
Bambino Gesù Hospital and Research Institute1
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma44
Leukemia12
Leukemia, Myeloid, Acute10
Myelodysplastic Syndromes9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Lymphoma6
Anemia, Refractory, with Excess of Blasts4
Burkitt Lymphoma4
Graft vs Host Disease4
Leukemia, Biphenotypic, Acute4

Trials

Showing 51 to 44 of 44. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.